News | August 11, 2021
Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22
Formulation business grew by 15 per cent in the quarter
Formulation business grew by 15 per cent in the quarter
The company has already embarked upon significant expansion in Turkey
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility features 2,176 high-performance GPUs across the US and Europe
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Subscribe To Our Newsletter & Stay Updated
